Form 4 · Filed Mar 17, 2026, 12:00 PM UTC
DNTH/Dianthus Therapeutics, Inc. /DE/
Garcia Marino — CEO AND PRESIDENT
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | M | other | 59,700 | $7 | $399,990 | 59,700 |
| Mar 16, 2026 | M | other | 5,592 | $18 | $99,985 | 65,292 |
| Mar 16, 2026 | M | other | 59,700 | $0 | — | 41 |
| Mar 16, 2026 | M | other | 5,592 | $0 | — | 269,408 |
Source: SEC EDGAR raw filing ↗ · Accession 0001669866-26-000007